Hong Kong Joyce Wong, managing director for APAC at compliance solutions provider Polaris in Hong Kong, describes the company’s innovative solutions for its clients in the life sciences, the significance of basing its regional headquarters in Hong Kong, and increasing compliance across the industry. It is very atypical for a senior executive…
Ireland Eoin Vaughan, CEO of Mercury Engineering, and Dermot Gildea, Director of Life Sciences, highlight the key priorities of their exciting new Mercury 2021 strategy, the rationale behind their transition into a sector-based company rather than a geography-based one, their commitment to continuous improvement in terms of staff capabilities and technology,…
Ukraine Roman Gladkyi, general manager of Ferring Ukraine, describes the current opportunities and areas for improvement he identifies within Ukraine’s pharmaceutical market and the country’s evolving heath system, with a special focus on Ferring’s key areas of expertise such as reproductive health and obstetric products. You have been heading Ferring Ukraine…
Indonesia Agus Heru Darjono, President Director at Metro Drug Indonesia, highlights the opportunities in the Indonesian Third Party Commercialization sector and emphasizes the importance of building the best team in order to successfully perform in an ever-changing market like Indonesia. Can you briefly speak towards the history as well as the…
Indonesia Endang Hoyaranda, Commissioner and President Director at Prodia Group, elaborates on Prodia’s pioneering spirit when implementing its diversification business strategy and explains how the company has successfully completed its IPO process on the Indonesian stock exchange (IDX). Prodia recently completed its IPO in the Indonesian stock market (IDX) issuing 25…
Taiwan Jassy Wang, CEO of MegaPro Biomedical, a nanomedicine development company specializing in developing nanoparticles and nanomicelles, discusses the evolving nanomedicine market in Taiwan and reveals the company’s plans for future growth. Can you introduce MegaPro Biomedical to our readers? “Nanosize features many advantages; amongst them I would highlight the ability…
Taiwan Eric Tsao, founder of Synermore Biologics, talks about how a company employing 90 people can successfully operate internationally and efficiently progress with its biosimilar and innovative product development pipeline. He also discusses what business strategy and potential partnerships will determine the successful growth of the company in the future. You…
Indonesia Dr. Agus Prabowo, chairman at LKPP (the Indonesian National Public Procurement Agency) explains the importance of embracing technology to gain efficiency and effectiveness in the public procurement process of healthcare products as well as the outcomes from e-catalogue implementation in Indonesia. Could you please introduce the main activities of LKPP…
Mexico José Antonio Garcia, CEO of Vensi, describes how the company’s unique service model is redefining how healthcare institutions approach the purchasing of medical equipment, while detailing the strategic significance of the recently award IMSS contract in validating their business model and augmenting future business prospects. Could you please introduce yourself…
Switzerland Despite increasing consolidation in the clinical trial industry, there’s enough market share to go around says SOCAR Research CEO Bridget-Anne Kirwan. For SOCAR Research, it’s the company’s strong academic roots in addition to personalized, tailored and innovative services that have helped to make the difference. To begin, could you please…
Switzerland With more than 20 years of experience working with the Swiss pharmaceutical sector, general manager Roland Laudenbacher explains that Honeywell Building Solutions has developed a true specialization in projects for pharma clients, including their own in house GMP validation services. To begin, could you please introduce Honeywell Business Solutions, and…
Mexico Aimed to ignite a paradigm shift away from the current traditional distributor model, Salumedic’s Managing Director, Gabriel Tagle, shares the novel business concept with zeal and sharp business acumen. He speaks about Saludemic’s core value preposition of being a “commercial hand” to key healthcare players, the crucial importance of proper…
See our Cookie Privacy Policy Here